|
|
Other links at Articles > Family Medicine |
| 2. |
FDA Approvals: Kuvan, Protonix, Kaletra
|
|
|
The FDA has approved sapropterin dihydrochloride tablets (Kuvan), pantoprazole sodium delayed-release oral suspension (Protonix), and a low-dose tablet formulation of lopinavir/ritonavir (Kaletra). Medscape Medical News
|
| 3. |
Burden of Dizziness and Vertigo High in the Community
|
|
|
A new population-based study suggests dizziness and vertigo occur frequently, with a prevalence of 23% in the past year and an incidence of about 3%. The authors urge a high index of suspicion to make a correct diagnosis. Medscape Medical News
|
|
|